A New Tool for Helping Labs Improve Diversity in Clinical Trials
Rachel Rangel, AuD, discusses a new toolkit to help laboratory professionals ensure diversity and inclusion is addressed in their research.
Open Content
Subscribe today for access to
Articles and Reports
G2 Intelligence Has Some Exciting News to Share!
G2 Intelligence to change subscription model to better serve the laboratory industry with more analysis and insight
Is a Newly Proposed Rule Meant to Stop Healthcare Consolidation?
The new rule put forth by the FTC and DOJ would make mergers and acquisitions much more difficult to achieve.
Sutter Health Pays Millions to Settle Improper Billing Claims
The healthcare services provider will be on the hook for $13 million for alleged improper billing of lab tests.
Healthcare Providers Frequently Targeted in Racial Incidents
A new analysis by ECRI shows that, while patients are also common targets, providers had to face racist behavior or comments most often.
Lab Institute Who’s Who: Mason Shaw
Learn more about how to tackle the key staffing challenges facing diagnostics laboratories today and tomorrow.
Lab Institute Who’s Who: Edward Dooling
Learn more about practical ways you can handle today’s lab staffing challenges, and how to prepare for those of the future.
Abbott Scores First FDA Greenlight for Commercial Use of Monkeypox Test
Abbott’s Alinity m MPXV assay for detecting DNA from the monkeypox virus received FDA EUA on Oct. 7.
Lab Institute Who’s Who: Joyce Gresko
Learn more about how Congress could change PAMA, why it matters to your lab, and how you can prepare.
How COVID-19 Transformed Healthcare Delivery
The pandemic came with great pain and suffering for many, but it also allowed telehealth and other technologies to flourish.
Lab Institute Who’s Who: John (JD) Donnelly
Learn more about how leveraging data automation to get clean patient data at the front end can be a game changer for labs.
FDA Launches Pilot Program to “De-risk the Medical Device Valley of Death”
The CDRH Total Product Life Cycle Advisory Program Pilot aims to improve the FDA authorization process for medical devices.
Congress Passes New FDA Medical Devices User Fee Amendments (MDUFA V) Deal
The new deal provides the FDA a minimum of $1.78 billion in user fees from 2023 to 2027.
